Bischloroanthrabenzoxocinone
Bischloroanthrabenzoxocinone is a potent Type II fatty acid synthesis (FASII) inhibitor. Bischloroanthrabenzoxocinone inhibits fatty acid synthesis. Bischloroanthrabenzoxocinone shows antibacterial activities and inhibits phospholipid, DNA, RNA, protein, and cell wall synthesis[1].
Product Specifications
CAS Number
[866022-28-8]
Product Name Alternative
(-) -BABX
UNSPSC
12352005
Target
Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/bischloroanthrabenzoxocinone.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C(C2)=CC(C(C)(C3=C4Cl)C)=C1C(C3=C(C(Cl)=C4O)O)=O)[C@](O[C@@]25C)([H])C(C(O5)=CC(OC)=C6)=C6C
Molecular Formula
C28H24Cl2O7
Molecular Weight
543.39
References & Citations
[1]Kodali S, et al. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. J Biol Chem. 2005 Jan 14;280 (2) :1669-77.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Human adenovirus C serotype 6 Early E3 18.5 kDa glycoprotein, partial
Recombinant Human adenovirus C serotype 6 Early E3 18.5 kDa glycoprotein, partial
Lentiviral mouse Lcn8 shRNA (UAS) - Lentiviral mouse Lcn8 shRNA (UAS, iRFP) (25)